Array Technologies, Inc. (NASDAQ: ARRY) has traded sharply higher on its debut in trading. The New Mexico-based maker of solar ground mounting systems and “trackers” priced its initial...
Array Technologies intends to price more than 33 million shares so that the entire initial public offering is valued up to about $815 million.
The parent of Array Technologies has amended its filing with the SEC regarding its initial public offering.
Aclaris Therapeutics has received an update from FDA regarding the use of its ATI-450 in hospitalized patients with COVID-19.
With Alcoa being a leader in aluminum, the problem here is that many investors see problems in aluminum also translating into problems for companies involved in steel, copper, titanium and other...
Wednesday's top analyst upgrades, downgrades and initiations included Agilent Technologies, American Power, Apache, Boeing, Ciena, Cisco, FireEye, Palo Alto Networks, Sony, Southwest Airlines and...
Thursday was a breakout day for a few biotech companies. Some made absolutely massive runs, while others fell off a cliff.
Aclaris Therapeutics shares sharply dropped early on Thursday after the firm announced results from its midstage trial in alopecia areata.
Baldness is something that many men fear as they age, and understandably so. But Aclaris Therapeutics may have found an answer to it in its most recent mid-stage clinical trial.
The top analyst upgrades, downgrades and other research calls from Monday include Alibaba, CarMax, Nike, PVH, RadWare, Under Armour and VF.
Friday morning's analyst calls are led by a price target raises on AMD and Domino's Pizza. Other firms getting some new attention are United Technologies, Sarepta Therapeutics, and Cadence Bancorp.
Due to higher demand and fewer imports, the price for steel is going higher, and the analysts at Merrill Lynch feel that numerous companies in the industry look poised to benefit.
24/7 Wall St. has tracked multiple stocks tied to steel and aluminum, and most of them saw impressive gains last week, and even into this week.
The top analyst upgrades, downgrades and other research calls from Friday include BioMarin, CSX, Kinder Morgan, Microsemi, Splunk, U.S. Steel and Walmart.
If there is one thing that can create an instant unilateral gain in a sector, government protection can do just that.